CA2243229A1 - Preparations a base de proteine d'obesite - Google Patents

Preparations a base de proteine d'obesite Download PDF

Info

Publication number
CA2243229A1
CA2243229A1 CA 2243229 CA2243229A CA2243229A1 CA 2243229 A1 CA2243229 A1 CA 2243229A1 CA 2243229 CA2243229 CA 2243229 CA 2243229 A CA2243229 A CA 2243229A CA 2243229 A1 CA2243229 A1 CA 2243229A1
Authority
CA
Canada
Prior art keywords
protein
formulation
obesity
solution
stock
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2243229
Other languages
English (en)
Inventor
Allen Howard Pekar
Steven Witt Dodd
John Michael Beals
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602408.8A external-priority patent/GB9602408D0/en
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US1997/000864 external-priority patent/WO1997026004A1/fr
Publication of CA2243229A1 publication Critical patent/CA2243229A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention porte sur une préparation parentérale soluble comprenant la protéine d'obésité et un agent conservateur, pouvant être de l'alkylparabène, du chlorobutanol ou leur mélange.
CA 2243229 1996-01-19 1997-01-17 Preparations a base de proteine d'obesite Abandoned CA2243229A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1022996P 1996-01-19 1996-01-19
US60/010,229 1996-01-19
GBGB9602408.8A GB9602408D0 (en) 1996-02-07 1996-02-07 Obesity protein formulations
GB9602408.8 1996-02-07
PCT/US1997/000864 WO1997026004A1 (fr) 1996-01-19 1997-01-17 Preparations a base de proteine d'obesite

Publications (1)

Publication Number Publication Date
CA2243229A1 true CA2243229A1 (fr) 1997-07-24

Family

ID=29424163

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2243229 Abandoned CA2243229A1 (fr) 1996-01-19 1997-01-17 Preparations a base de proteine d'obesite

Country Status (1)

Country Link
CA (1) CA2243229A1 (fr)

Similar Documents

Publication Publication Date Title
EP0725078A1 (fr) Protéines contre obesité
EP0810872A1 (fr) Proteines agissant contre l'obesite
WO1996023513A1 (fr) Proteines anti-obesite
WO1997035620A1 (fr) Formulations de proteine ob
WO1997026004A1 (fr) Preparations a base de proteine d'obesite
EP0786256A2 (fr) Préparation des protéines contre l'obésité
WO1997026012A1 (fr) Formulations d'une proteine de l'obesite
US5831017A (en) Obesity protein analog compounds and formulations thereof
EP0784982A2 (fr) Préparation des protéines contre l'obésité
EP0835879A2 (fr) Analogues des protéines d'obésité et formulations pharmaceutiques les contenant
EP0827750A2 (fr) Préparations des protéines contre l'obésité
CA2243229A1 (fr) Preparations a base de proteine d'obesite
EP0889737A1 (fr) Compose contenant la proteine de l'obesite et leurs formulations
AU723997B2 (en) Obesity protein formulations
JP2001507228A (ja) 抗肥満タンパク質
CA2243512A1 (fr) Formulations d'une proteine de l'obesite
CA2243518A1 (fr) Formulations de proteine de l'obesite
CA2243707A1 (fr) Compose contenant la proteine de l'obesite et leurs formulations
WO1998031390A1 (fr) Composition a base de proteines de l'obesite
CA2243825A1 (fr) Composes d'analogues de proteines de l'obesite et preparations a base de ceux-ci
CA2211784A1 (fr) Proteines anti-obesite

Legal Events

Date Code Title Description
FZDE Dead